Full Text View
Tabular View
No Study Results Posted
Related Studies
L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis
This study has been completed.
Study NCT00851838   Information provided by Iperboreal Pharma Srl

First Received on February 25, 2009.   Last Updated on March 25, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
End-Stage Renal Disease
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
More general conditions related to this trial
Renal Insufficiency
Renal Insufficiency, Chronic
Urologic Diseases
Interventions listed in this trial
L-Carnitine
Additional drug interventions recognized in this trial
Carnitine
More general drug interventions related to this trial
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Iperboreal Pharma Srl


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services